C12Y302/01014

Chitinase proteins in neurologic disease
12050217 · 2024-07-30 · ·

The present disclosure describes methods of determining a treatment protocol for and/or a prognosis for a subject suspected of or at risk of suffering from a neurologic disease or disorder, including such diseases and disorders that involve motor neuron function such as ALS. The methods comprise detecting the presence of a chitinase protein in a biological sample.

Chromobacterium Subtsugae Genome

Disclosed herein is the nucleotide sequence of the Chromobacterium subtsugae genome. Also provided are the nucleotide sequences of open reading frames in the C subtsugae genome (i.e., C. subtsugae genes). In addition, the amino acid sequences of proteins encoded by the C. subtsugae genome are provided. Nucleic acids, vectors and polypeptides comprising the aforementioned sequences are also provided. Homologues, functional fragments and conservative variants of the aforementioned sequences are also provided. Compositions having pesticidal, bioremedial and plant growth-promoting activities comprising C. subtsugae genes and proteins, and methods for the use of these compositions, are also provided.

METHODS AND COMPOSITIONS FOR DETECTING COCCIDIOIDOMYCOSIS
20190049447 · 2019-02-14 ·

Methods and compositions for detecting Coccidioidomycosis featuring amino acids 105-310 of the Cts1 protein or amino acids 111-310 of the Cts1 protein; or peptide sequences that are similar to amino acids 105-310 of the Cts1 protein or similar to amino acids 111-310 of the Cts1 protein. Compared to standard immunodiffusion testing of undiluted sera for these antibodies, the present invention shows specific detection above non-immune sera at 1:100 dilution. The methods and compositions of the present invention help reduce the non-specific antibody binding unrelated to acquiring a coccidioidal infection, thereby providing a more sensitive test for early coccidioidal infection because signal could be distinguished at lower intensity, avoiding confusion with nonspecific antibody binding.

Methods of protecting a plant from a fungal pest

A method of controlling or preventing pathogenic damage and/or pest damage in a plant propagation material, a plant, part of a plant and/or plant organ, comprising applying on the plant, part of the plant, plant organ, plant propagation material or a surrounding area thereof a phytoprotective agent comprising an enzyme and a fungicide.

NUCLEIC ACID MOLECULES

The present disclosure relates to a nucleic acid molecule comprising 5-UTR and/or 3-UTR sequences that yield high translation levels. Aspects of the disclosure further relate to nucleic acid molecules suitable for use as a vaccine in the treatment and prevention of infectious diseases, including those caused by a coronavirus, compositions comprising said nucleic acid molecules and methods of treating or preventing infectious diseases.

ACHOLETIN BIOPOLYMERS AND METHODS FOR ENZYMATIC SYNTHESIS

Provided herein are ?-1,3-linked biopolymers (acholetin polysaccharides). Furthermore, provided herein are enzymatic methods and systems for producing ?-1,3-linked oligosaccharides and polysaccharides using ?-1,3-N-acetylglucosaminide phosphorylase (Acholetin phosphorylase (AchP)). The AchP was sourced from the genome of the cell wall-less Mollicute bacterium, Acholeplasma laidlawii and was found to synthesize ?-1,3-linked N-acetylglucosamine (GlcNAc) or N-acetylgalactosamine (GalNAc) oligomers using the donor. ?-N-acetylglucosamine 1-phosphate (GlcNAc1-P) or N-acetylgalactosamine 1-phosphate (GalNAc1-P).

CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS

The present invention relates to chitinolytic enzymes, and in particular for a use thereof in plant protection. The invention also relates to a nucleic acid encoding a chitinolytic enzyme a method for producing a chitinolytic enzyme, a plant comprising a chitinolytic enzyme or a nucleic acid encoding the same, a composition of at least one chitinolytic enzyme. The invention relates in particular to the use of a chitinolytic enzyme or a composition comprising the same as a plant protection agent and to a method of protecting plants from pests.

CHITINASE PROTEINS IN NEUROLOGIC DISEASE
20240302372 · 2024-09-12 ·

The present disclosure describes methods of determining a treatment protocol for and/or a prognosis for a subject suspected of or at risk of suffering from a neurologic disease or disorder, including such diseases and disorders that involve motor neuron function such as ALS. The methods comprise detecting the presence of a chitinase protein in a biological sample.

STRUCTURING FATS AND METHODS OF PRODUCING STRUCTRING FATS

Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsatturated-saturated type.

Insecticidal chitinase protein its encoding nucleotide and application thereof

A novel insecticidal chitinase protein from fern Tectaria sp., a process for preparation of the insecticidal protein and nucleic acid sequence encoding for said insecticidal protein and its application for insect control purposes.